REDWOOD CITY, CA
Allocation by class
Portfolio Concentration
Top 3 weight
56.8%
Top 10 weight
96.5%
Voting Authority Distribution
Total shares with voting rights: 35.69M
Full voting authority
35.69M
shares
Joint voting authority
0.00
shares
No voting authority
0.00
shares
Investment Discretion (by position count)
| Issuer | Class | Shares | Type | Value / Portfolio % | Voting — Sole | Shared | None |
|---|---|---|---|---|---|---|---|
Arcellx, Inc.SOLE | Common Stock | 2.35M | SH | $269.44M 29.43% | 2.35M | 0.00 | 0.00 |
Veradermics, Inc.SOLE | Common Stock | 2.40M | SH | $151.68M 16.57% | 2.40M | 0.00 | 0.00 |
Zenas BioPharma, IncSOLE | Common Stock | 5.04M | SH | $98.49M 10.76% | 5.04M | 0.00 | 0.00 |
CRISPR Therapeutics AGSOLE | Common Shares | 2.04M | SH | $96.98M 10.59% | 2.04M | 0.00 | 0.00 |
Design Therapeutics, Inc.SOLE | Common Stock | 6.53M | SH | $69.44M 7.59% | 6.53M | 0.00 | 0.00 |
ORIC Pharmaceuticals, Inc.SOLE | Common Stock | 4.51M | SH | $58.48M 6.39% | 4.51M | 0.00 | 0.00 |
Alumis Inc.SOLE | Common Stock | 1.96M | SH | $43.18M 4.72% | 1.96M | 0.00 | 0.00 |
Mineralys Therapeutics Inc.SOLE | Common Stock | 1.56M | SH | $42.37M 4.63% | 1.56M | 0.00 | 0.00 |
ARS Pharmaceuticals, Inc.SOLE | Common Stock | 4.01M | SH | $32.22M 3.52% | 4.01M | 0.00 | 0.00 |
Oruka Therapeutics, IncSOLE | Common Stock | 430.33K | SH | $21.11M 2.31% | 430.33K | 0.00 | 0.00 |
Oculis Holding AGSOLE | Ordinary Shares | 641.02K | SH | $17.04M 1.86% | 641.02K | 0.00 | 0.00 |
Nkarta, Inc.SOLE | Common Stock | 3.33M | SH | $7.03M 0.77% | 3.33M | 0.00 | 0.00 |
enGene Holdings Inc.SOLE | Common Shares | 747.75K | SH | $5.09M 0.56% | 747.75K | 0.00 | 0.00 |
Ultragenyx Pharmaceutical Inc.SOLE | Common Stock | 137.75K | SH | $2.89M 0.32% | 137.75K | 0.00 | 0.00 |